Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
3.56
-0.35 (-8.95%)
At close: May 23, 2025, 3:59 PM
3.60
0.98%
After-hours: May 23, 2025, 04:00 PM EDT
-8.95% (1D)
| Bid | 3.45 |
| Market Cap | 92.23M |
| Revenue (ttm) | 242K |
| Net Income (ttm) | -49.83M |
| EPS (ttm) | -2.49 |
| PE Ratio (ttm) | -1.43 |
| Forward PE | -1.3 |
| Analyst | Buy |
| Ask | 3.79 |
| Volume | 100,645 |
| Avg. Volume (20D) | 75,807 |
| Open | 3.80 |
| Previous Close | 3.91 |
| Day's Range | 3.50 - 3.80 |
| 52-Week Range | 3.42 - 22.00 |
| Beta | 0.70 |
About CTNM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTNM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTNM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
2 months ago · businesswire.com
Contineum Therapeutics to Present at the Stifel 2025 Virtual CNS ForumSAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of ...
